Catalent expands biologics facility, to create 36 new jobs
Catalent is expanding its US biologics packaging facility, following recent investments and expansions in the Asia-Pacific region.
Archives for December 4, 2018
GSK rebuilds oncology pipeline with $5.1bn acquisition
GSK entered an agreement with Tesaro to gain ‘under-appreciated’ PARP inhibitor assets and a Boston base.
FDA’s MyStudies release is a ‘major milestone’ with ‘profound’ implications, says Iqvia
The FDA recently released open source code and technical documents for its new mobile app – MyStudies – which is designed to collect information about medication use, health system touchpoints, and patient-reported outcomes.
eClinical market to reach $13bn by 2024: Aggressive growth fueled by new entrants, consolidation
The eClinical industry is in an “aggressive” growth phase as the big players double down on R&D and acquire mid-sized companies.
The top 15 wearables for incorporating real-world data into clinical trials
Litmus Health’s profile of the wearables market names the top 15 devices today available to researchers incorporating real-life data into studies and trials – with a focus on data quality and transparency.
Biovation invests in equipment able to create any tablet on the market
Biovation expands its technology portfolio with all-encompassing tableting equipment to grow its production capacity and change specifications ‘on the fly’.
Unilever to acquire Horlicks and GSK’s Health Food Drinks portfolio
Unilever will acquire GlaxoSmithKline’s Health Food Drinks portfolio in Asia for €3.3bn ($3.8bn): a move that will boost its presence in the Indian market.